Dopamine Hci Injection, Solution, Concentrate
Product Images NDC 51662-1291

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Dopamine Hci (NDC 51662-1291). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Desc Structure)

Chemical structure diagram of dopamine hydrochloride, showing a benzene ring with two hydroxyl groups and an ethylamine side chain bound to hydrochloride.*

FDA Label Image

Precautions 1 (Untitled)

A drug information text panel titled 'IMPORTANT' focusing on the antidote for peripheral ischemia. It instructs on using phentolamine mesylate solution to treat ischemic areas caused by extravasation, including dosage guidance, administration method, and timing for effective treatment to prevent tissue necrosis.*

FDA Label Image

Dosage 1 (Dosage And Admin)

Table showing concentrations of dopamine hydrochloride injection solutions at 40 mg/mL and 80 mg/mL strengths, with associated dopamine microgram per milliliter (mcg/mL) levels for 250 mL, 500 mL, and 1000 mL intravenous solution bottles, and volumes of dopamine hydrochloride injection in milliliters (5 mL, 10 mL).*

FDA Label Image

How Supplied 1 (How Supplied)

A data table showing units of sale and concentration strengths for dopamine HCl injection solution concentrate. The table lists two NDCs: 0409-5820-01 with 200 mg/5 mL (40 mg/mL), and 0409-9104-20 with 400 mg/10 mL (40 mg/mL). Both come 25 in a carton.*

FDA Label Image

Logo (How Supplied Logo)

FDA Label Image

Vial Label (1007700 0409 5820 01 Dopamine Vial)

Label for DOPamine HCl Injection, USP 200 mg (40 mg/mL) single-dose 5 mL vial. The label states the product is for intravenous use only and must be diluted. It lists the manufacturer as HOSPIRA, INC., located in Lake Forest, IL 60045 USA, with NDC 0409-5820-01. The label includes information on additional inactive ingredients such as sodium metabisulfite, citric acid, sodium citrate, and sodium added as buffer.*

FDA Label Image

Rfid Label (51662 1291 1 Rfid Label)

Dopamine HCl injection label showing a barcode and text including a National Drug Code (NDC) associated number sequence. The label references HF Acquisitions Co., LLC as the distributor located in Mukilteo, WA. The word 'RX ONLY' is printed vertically next to a 2D barcode. Additional code sequences and text 'SEE MANUFACTURE'S INSERT' are visible.*

FDA Label Image

Pouch Labeling (51662 1291 2 Pouch Labeling Sept 2022)

Label for Dopamine HCl Injection USP 200 mg/5 mL (40 mg/mL) solution concentrate in a 5 mL vial. The label includes NDC 51662-1291-2, lot and expiration information, dilution and use instructions, storage temperature (20 to 25°C), cautionary notes, and manufacturer details: HF Acquisition Co LLC, Mukilteo, WA.*

FDA Label Image

Vial Label (Vial Label Sept 2022)

Label for DOPamine HCl Injection USP, 200 mg/5 mL (40 mg/mL) single-dose solution. The label states it must be diluted and is for intravenous use only. It lists sodium metabisulfite, citric acid, and sodium citrate as additives. The product is distributed by Hospira, Inc., Lake Forest, IL.*

FDA Label Image

Case Labeling (51662 1291 3 Case Labeling Sept 2022)

DOPAMINE HCI Injection, USP 200 mg per 5 mL vial (40 mg/mL), packaged as a 5 mL vial in a case of 25. The label includes NDC 51662-1291-3 and indicates the product is manufactured by HF Acquisition Co LLC, DBA HealthFirst. The label also shows lot number, expiration date, dilution and storage instructions, and cautions for intravenous use only.*

FDA Label Image

Rfid Label (51662 1291 3 Rfid)

Partial label of Dopamine HCl injection solution concentrate showing serialized data, including GS1 barcodes and text instructing to see the manufacturer's insert. Distributed by HF Acquisitions Co., LLC, Mukilteo, WA. No strength or dosage form details are visible on this portion of the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.